Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Christine Walsh

Concepts (364)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
50
2024
604
7.650
Why?
Poly(ADP-ribose) Polymerase Inhibitors
6
2024
139
2.020
Why?
Neoplasms, Glandular and Epithelial
12
2022
52
1.960
Why?
Endometrial Neoplasms
11
2022
205
1.900
Why?
BRCA2 Protein
8
2021
69
1.550
Why?
BRCA1 Protein
8
2020
84
1.550
Why?
Genes, BRCA1
10
2023
45
1.290
Why?
Genes, BRCA2
9
2023
33
1.280
Why?
Peritoneal Neoplasms
4
2018
103
1.140
Why?
Adenocarcinoma, Clear Cell
4
2016
14
1.130
Why?
Cystadenocarcinoma, Serous
9
2019
90
1.000
Why?
Biomarkers, Tumor
8
2022
1339
0.870
Why?
Maintenance Chemotherapy
2
2024
41
0.860
Why?
Germ-Line Mutation
6
2016
180
0.800
Why?
Neoplasm Recurrence, Local
13
2024
1160
0.780
Why?
Indazoles
2
2020
86
0.770
Why?
Bevacizumab
2
2020
169
0.760
Why?
Neoplasm Staging
14
2021
1488
0.750
Why?
Piperidines
2
2020
225
0.710
Why?
Myeloproliferative Disorders
1
2021
22
0.690
Why?
Sleep, REM
2
2023
45
0.670
Why?
Polymorphism, Single Nucleotide
15
2018
2240
0.650
Why?
Gray Matter
1
2021
96
0.630
Why?
Phthalazines
1
2020
64
0.620
Why?
Sleep Apnea Syndromes
1
2021
98
0.610
Why?
Genetic Predisposition to Disease
15
2023
2488
0.610
Why?
Deoxycytidine
1
2021
219
0.610
Why?
Female
75
2024
79499
0.600
Why?
Mutation
14
2023
4093
0.580
Why?
Cisplatin
1
2021
347
0.580
Why?
Fallopian Tube Neoplasms
2
2016
20
0.570
Why?
Aged, 80 and over
23
2021
8391
0.570
Why?
Genital Neoplasms, Female
3
2018
100
0.570
Why?
White Matter
2
2020
169
0.560
Why?
Molecular Targeted Therapy
3
2017
447
0.560
Why?
Piperazines
2
2020
368
0.560
Why?
Tumor Suppressor Protein p53
1
2022
530
0.550
Why?
Genetic Testing
3
2017
492
0.540
Why?
Sleep Initiation and Maintenance Disorders
1
2021
198
0.540
Why?
Medical Oncology
2
2020
345
0.540
Why?
Gynecology
1
2020
185
0.540
Why?
Breast Neoplasms
11
2023
2418
0.530
Why?
Thromboplastin
1
2017
67
0.500
Why?
Antineoplastic Agents
3
2018
2219
0.500
Why?
Humans
82
2024
146342
0.490
Why?
Fellowships and Scholarships
1
2020
355
0.480
Why?
Aged
37
2021
26432
0.480
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2023
42
0.470
Why?
DNA Repair-Deficiency Disorders
1
2016
5
0.470
Why?
Digoxin
1
2015
27
0.460
Why?
Antibodies, Monoclonal, Humanized
1
2021
992
0.430
Why?
Venous Thrombosis
1
2017
199
0.430
Why?
Carcinoma, Endometrioid
2
2014
49
0.410
Why?
DNA-Binding Proteins
3
2012
1468
0.410
Why?
Hysterectomy
4
2009
139
0.400
Why?
Prognosis
16
2022
4351
0.390
Why?
Organoplatinum Compounds
2
2015
65
0.390
Why?
Survival Rate
9
2021
2092
0.380
Why?
Middle Aged
39
2021
36619
0.370
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2021
1998
0.370
Why?
Enzyme Inhibitors
1
2016
823
0.360
Why?
Loss of Heterozygosity
2
2008
51
0.350
Why?
Cystadenocarcinoma, Papillary
2
2008
4
0.350
Why?
Nuclear Proteins
4
2016
740
0.340
Why?
Cognition
1
2020
1292
0.340
Why?
Adenocarcinoma, Papillary
1
2011
11
0.340
Why?
Ovariectomy
4
2023
164
0.320
Why?
Neoplasms, Multiple Primary
2
2014
57
0.320
Why?
DNA, Neoplasm
4
2014
160
0.310
Why?
Alzheimer Disease
3
2023
641
0.300
Why?
Internship and Residency
1
2020
1281
0.300
Why?
Venous Thromboembolism
1
2013
332
0.290
Why?
Platinum
2
2021
48
0.290
Why?
Uniparental Disomy
1
2008
9
0.280
Why?
Uterine Neoplasms
4
2014
98
0.280
Why?
DNA Repair
1
2011
255
0.280
Why?
Transcription Factors
4
2016
1730
0.270
Why?
Endonucleases
1
2008
35
0.270
Why?
Indoles
2
2024
511
0.270
Why?
Homologous Recombination
2
2020
38
0.270
Why?
Adult
31
2021
41087
0.260
Why?
Disease-Free Survival
5
2013
778
0.250
Why?
CA-125 Antigen
2
2021
13
0.250
Why?
Risk Factors
14
2023
10921
0.250
Why?
Drug Resistance, Neoplasm
4
2022
893
0.240
Why?
Proto-Oncogene Proteins c-mdm2
1
2006
66
0.240
Why?
Checkpoint Kinase 2
2
2016
27
0.240
Why?
Neoplasms
1
2021
2954
0.230
Why?
United States
7
2024
16136
0.230
Why?
Vaginal Neoplasms
2
2016
20
0.220
Why?
Surgical Wound Infection
1
2009
349
0.220
Why?
Survival Analysis
5
2017
1378
0.220
Why?
Anisotropy
3
2020
77
0.210
Why?
Obesity, Morbid
1
2009
287
0.210
Why?
Drug Approval
1
2024
94
0.200
Why?
United States Food and Drug Administration
1
2024
208
0.200
Why?
Neoplasms, Unknown Primary
1
2023
20
0.190
Why?
Medicare
2
2020
920
0.180
Why?
Neoplasm Grading
7
2019
313
0.180
Why?
Immunohistochemistry
3
2019
1712
0.180
Why?
Transforming Growth Factor beta
2
2016
467
0.180
Why?
ras Proteins
2
2015
148
0.180
Why?
Lewy Body Disease
1
2022
33
0.180
Why?
DNA Methylation
2
2022
725
0.180
Why?
Molecular Diagnostic Techniques
1
2022
104
0.170
Why?
Case-Control Studies
6
2017
3647
0.170
Why?
Diffusion Magnetic Resonance Imaging
2
2020
158
0.170
Why?
Endometriosis
1
2022
58
0.170
Why?
Poly (ADP-Ribose) Polymerase-1
1
2021
55
0.170
Why?
Computing Methodologies
1
2020
3
0.170
Why?
Thrombocytosis
2
2014
6
0.160
Why?
Leydig Cell Tumor
1
2020
8
0.160
Why?
Benzamides
1
2021
226
0.160
Why?
Sleep Wake Disorders
2
2023
314
0.160
Why?
Population Surveillance
3
2020
481
0.160
Why?
Hyperandrogenism
1
2020
25
0.160
Why?
Adaptor Proteins, Signal Transducing
2
2016
429
0.160
Why?
Diffusion
1
2020
119
0.150
Why?
Optical Imaging
1
2020
63
0.150
Why?
Proto-Oncogene Proteins
2
2015
616
0.150
Why?
Genome-Wide Association Study
6
2022
1537
0.150
Why?
Drug Administration Schedule
1
2021
790
0.140
Why?
Retrospective Studies
13
2020
17438
0.140
Why?
Cell Line, Tumor
4
2016
3545
0.140
Why?
Fitness Trackers
1
2019
18
0.140
Why?
Risk Reduction Behavior
2
2018
220
0.140
Why?
B7-H1 Antigen
1
2021
245
0.140
Why?
Early Ambulation
1
2019
26
0.140
Why?
Guidelines as Topic
1
2020
267
0.140
Why?
Rho Guanine Nucleotide Exchange Factors
1
2018
27
0.140
Why?
Monomeric GTP-Binding Proteins
1
2018
16
0.140
Why?
Antineoplastic Agents, Immunological
1
2020
200
0.140
Why?
Angiogenesis Inhibitors
1
2020
239
0.130
Why?
Dementia
1
2022
324
0.130
Why?
Carcinoma in Situ
2
2016
45
0.130
Why?
Regression Analysis
1
2020
999
0.130
Why?
Cost-Benefit Analysis
1
2020
640
0.130
Why?
Enzyme Multiplied Immunoassay Technique
1
2017
2
0.130
Why?
A Kinase Anchor Proteins
1
2018
75
0.130
Why?
Cadherins
1
2019
202
0.130
Why?
Genetic Counseling
1
2017
82
0.120
Why?
Salpingectomy
1
2016
15
0.120
Why?
Remission Induction
1
2017
308
0.120
Why?
Postoperative Care
1
2019
301
0.120
Why?
Receptors, Transforming Growth Factor beta
1
2016
54
0.120
Why?
Randomized Controlled Trials as Topic
2
2020
1763
0.120
Why?
Oligonucleotide Array Sequence Analysis
2
2008
752
0.120
Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
69
0.120
Why?
Lymphocyte Activation
1
2020
1137
0.120
Why?
Extracellular Matrix Proteins
2
2015
156
0.120
Why?
Phosphotransferases (Alcohol Group Acceptor)
1
2016
51
0.120
Why?
Los Angeles
2
2018
73
0.120
Why?
Parkinson Disease
1
2022
614
0.110
Why?
Antigens, CD
1
2019
560
0.110
Why?
Clinical Trials as Topic
2
2013
1064
0.110
Why?
Cohort Studies
6
2016
6077
0.110
Why?
Chemotherapy, Adjuvant
1
2016
429
0.110
Why?
Genotype
6
2018
1879
0.110
Why?
Cyclin E
1
2015
23
0.110
Why?
Proto-Oncogene Proteins c-ets
1
2015
54
0.110
Why?
Gonadotropins
1
2014
44
0.110
Why?
SEER Program
1
2015
233
0.110
Why?
Lymph Node Excision
1
2016
174
0.110
Why?
Oncogene Proteins
1
2015
61
0.110
Why?
Enhancer Elements, Genetic
1
2016
190
0.110
Why?
Myofibroblasts
1
2016
149
0.100
Why?
Corpus Callosum
1
2014
76
0.100
Why?
Tumor Suppressor Proteins
1
2016
315
0.100
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2013
54
0.100
Why?
Promoter Regions, Genetic
2
2010
1242
0.100
Why?
ATP-Binding Cassette Transporters
1
2014
117
0.100
Why?
Interleukin-1alpha
1
2013
55
0.100
Why?
Early Detection of Cancer
3
2021
506
0.100
Why?
Heterozygote
4
2016
311
0.100
Why?
Receptor Protein-Tyrosine Kinases
1
2015
227
0.090
Why?
Patient Satisfaction
1
2017
706
0.090
Why?
Cancer Survivors
1
2018
348
0.090
Why?
Lymph Nodes
1
2016
511
0.090
Why?
Brain Mapping
1
2016
541
0.090
Why?
Time Factors
3
2021
7109
0.090
Why?
Length of Stay
1
2019
1358
0.090
Why?
Cell Adhesion Molecules
1
2013
180
0.090
Why?
Prefrontal Cortex
1
2016
339
0.090
Why?
Treatment Outcome
4
2021
11821
0.090
Why?
Adenocarcinoma
2
2011
927
0.090
Why?
Cognitive Dysfunction
1
2018
481
0.090
Why?
Chromosomes, Human, Pair 19
1
2012
28
0.090
Why?
Gene Expression Regulation, Neoplastic
4
2016
1432
0.090
Why?
Health Care Reform
1
2013
110
0.090
Why?
Endometrial Hyperplasia
1
2011
6
0.090
Why?
T-Lymphocytes
1
2020
2012
0.090
Why?
Chromosomes, Human
1
2011
45
0.080
Why?
Follow-Up Studies
5
2016
5439
0.080
Why?
Progestins
1
2011
67
0.080
Why?
Terminal Care
1
2015
284
0.080
Why?
Executive Function
1
2016
463
0.080
Why?
Surveys and Questionnaires
2
2021
6073
0.080
Why?
Prostatic Neoplasms
2
2016
972
0.080
Why?
Magnetic Resonance Imaging
2
2021
3926
0.080
Why?
Real-Time Polymerase Chain Reaction
3
2016
334
0.080
Why?
Genetic Association Studies
3
2018
379
0.080
Why?
Mass Screening
2
2010
1307
0.080
Why?
MutL Protein Homolog 1
1
2010
11
0.080
Why?
Fibroblasts
1
2016
1034
0.080
Why?
Interleukin-6
1
2014
784
0.080
Why?
Male
9
2021
73396
0.080
Why?
NF-kappa B
1
2013
674
0.080
Why?
Microsatellite Instability
1
2010
57
0.080
Why?
Mammography
2
2021
175
0.070
Why?
Leiomyomatosis
1
2009
4
0.070
Why?
Sleep
3
2023
896
0.070
Why?
Receptors, Estrogen
1
2012
406
0.070
Why?
Suction
1
2009
31
0.070
Why?
Incidence
4
2021
2936
0.070
Why?
Signal Transduction
4
2016
5246
0.070
Why?
Protein Kinase Inhibitors
1
2015
983
0.070
Why?
Polymerase Chain Reaction
1
2011
1031
0.070
Why?
Carcinoma, Papillary
1
2009
83
0.070
Why?
Artifacts
1
2009
143
0.070
Why?
Adenocarcinoma, Mucinous
1
2009
76
0.070
Why?
Cell Differentiation
1
2016
1982
0.070
Why?
Alleles
1
2011
907
0.070
Why?
Ovary
2
2020
236
0.070
Why?
Conization
1
2007
2
0.070
Why?
Blood Vessels
1
2009
164
0.060
Why?
Risk
3
2016
920
0.060
Why?
Gynecologic Surgical Procedures
1
2007
68
0.060
Why?
Registries
1
2015
2400
0.060
Why?
Pseudogenes
1
2006
20
0.060
Why?
Healthcare Disparities
1
2013
733
0.060
Why?
Fertility
1
2007
174
0.060
Why?
Genes, Tumor Suppressor
1
2005
84
0.050
Why?
Pilot Projects
2
2022
1888
0.050
Why?
Quantitative Trait Loci
2
2018
388
0.050
Why?
Membrane Proteins
1
2011
1130
0.050
Why?
MicroRNAs
1
2011
699
0.050
Why?
Lymphoma
1
2006
251
0.050
Why?
Kaplan-Meier Estimate
2
2019
970
0.050
Why?
Tumor Cells, Cultured
2
2016
882
0.050
Why?
Laparoscopy
1
2009
487
0.050
Why?
Uterine Cervical Neoplasms
1
2007
269
0.050
Why?
Phosphatidylinositol 3-Kinases
1
2006
384
0.050
Why?
Genetic Loci
2
2015
273
0.050
Why?
Leukemia
1
2006
246
0.050
Why?
Neoplasm Invasiveness
2
2019
504
0.050
Why?
Immunoenzyme Techniques
2
2016
197
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
974
0.050
Why?
Aging
1
2014
1996
0.050
Why?
Gene Expression
1
2008
1463
0.050
Why?
Age Factors
1
2010
3347
0.050
Why?
RNA, Messenger
3
2016
2791
0.050
Why?
Muscle Hypertonia
1
2022
8
0.050
Why?
Sensitivity and Specificity
1
2007
1998
0.050
Why?
Linear Models
2
2015
857
0.040
Why?
Transcriptome
2
2022
1068
0.040
Why?
Proto-Oncogene Proteins p21(ras)
2
2015
250
0.040
Why?
Algorithms
1
2010
1849
0.040
Why?
Practice Guidelines as Topic
1
2010
1591
0.040
Why?
Chromatin Immunoprecipitation
2
2016
139
0.040
Why?
Diagnosis, Differential
2
2016
1503
0.040
Why?
Virilism
1
2020
6
0.040
Why?
Sleep Deprivation
1
2023
207
0.040
Why?
Cell Movement
2
2016
951
0.040
Why?
Neuropsychological Tests
2
2016
1149
0.040
Why?
Prospective Studies
3
2019
8123
0.040
Why?
Young Adult
2
2016
14330
0.040
Why?
Epigenesis, Genetic
1
2005
712
0.040
Why?
California
1
2021
475
0.040
Why?
Ribonucleoproteins, Small Nucleolar
1
2019
5
0.040
Why?
Mastectomy
1
2020
189
0.040
Why?
Cell Proliferation
2
2016
2502
0.030
Why?
Apoptosis
2
2016
2439
0.030
Why?
Fanconi Anemia Complementation Group N Protein
1
2016
4
0.030
Why?
Testosterone
1
2020
419
0.030
Why?
Ultrasonography
1
2020
788
0.030
Why?
Receptors, Lysosphingolipid
1
2016
13
0.030
Why?
Databases, Factual
1
2021
1493
0.030
Why?
Electrophoretic Mobility Shift Assay
1
2016
90
0.030
Why?
Sphingosine
1
2016
46
0.030
Why?
Behavior Therapy
1
2018
291
0.030
Why?
Models, Anatomic
1
2016
87
0.030
Why?
Gene Frequency
1
2016
496
0.030
Why?
Lysophospholipids
1
2016
80
0.030
Why?
Fluorescent Antibody Technique
1
2016
345
0.030
Why?
Apathy
1
2015
8
0.030
Why?
Aurora Kinase A
1
2015
57
0.030
Why?
Factor Analysis, Statistical
1
2016
298
0.030
Why?
Disease Progression
2
2016
2867
0.030
Why?
Oxazoles
1
2015
48
0.030
Why?
E2F Transcription Factors
1
2015
65
0.030
Why?
Likelihood Functions
1
2015
138
0.030
Why?
Hyaluronan Receptors
1
2015
105
0.030
Why?
ATP Binding Cassette Transporter 1
1
2014
13
0.030
Why?
Lymphatic Metastasis
1
2016
335
0.030
Why?
Mammary Glands, Human
1
2015
71
0.030
Why?
Neurologic Examination
1
2015
129
0.030
Why?
Nucleotides
1
2015
128
0.030
Why?
Phenotype
1
2023
3206
0.030
Why?
Thiazoles
1
2015
139
0.030
Why?
Random Allocation
1
2015
366
0.030
Why?
Microtubule-Associated Proteins
1
2015
187
0.030
Why?
Tubulin
1
2015
124
0.030
Why?
Cyclin-Dependent Kinases
1
2015
121
0.020
Why?
Genetic Markers
1
2014
340
0.020
Why?
Microarray Analysis
1
2013
117
0.020
Why?
DNA Mutational Analysis
1
2014
410
0.020
Why?
Estrogen Receptor alpha
1
2015
154
0.020
Why?
Blotting, Western
1
2016
1177
0.020
Why?
Memory, Short-Term
1
2016
276
0.020
Why?
Electronic Health Records
1
2021
1210
0.020
Why?
T-Lymphocytes, Regulatory
1
2016
415
0.020
Why?
Carcinogenesis
1
2015
226
0.020
Why?
Age of Onset
1
2015
558
0.020
Why?
Mice, Nude
1
2015
668
0.020
Why?
Cells, Cultured
1
2020
4118
0.020
Why?
Attention
1
2016
463
0.020
Why?
Hospice Care
1
2015
230
0.020
Why?
Vagina
1
2014
202
0.020
Why?
Xenograft Model Antitumor Assays
1
2015
930
0.020
Why?
Phosphorylation
1
2016
1724
0.020
Why?
Advance Care Planning
1
2015
244
0.020
Why?
Evolution, Molecular
1
2015
502
0.020
Why?
Premenopause
1
2011
130
0.020
Why?
Chromosomes, Human, Pair 6
1
2011
51
0.020
Why?
Chromosomes, Human, Pair 1
1
2011
82
0.020
Why?
Biomarkers
1
2022
4340
0.020
Why?
Cell Cycle Proteins
1
2015
630
0.020
Why?
Referral and Consultation
1
2017
881
0.020
Why?
Health Personnel
1
2017
754
0.020
Why?
Predictive Value of Tests
1
2016
2113
0.020
Why?
Pyridines
1
2015
610
0.020
Why?
3' Untranslated Regions
1
2011
152
0.020
Why?
Neoplastic Stem Cells
1
2014
403
0.020
Why?
Precancerous Conditions
1
2011
162
0.020
Why?
Logistic Models
1
2014
2126
0.020
Why?
Mice, Knockout
1
2016
3125
0.020
Why?
Transcription, Genetic
1
2015
1432
0.020
Why?
Carboplatin
1
2009
168
0.020
Why?
Multivariate Analysis
1
2011
1543
0.020
Why?
Mice
2
2016
18297
0.020
Why?
Brachytherapy
1
2009
132
0.020
Why?
Paclitaxel
1
2009
260
0.020
Why?
Parity
1
2007
113
0.020
Why?
Medical Records
1
2007
193
0.020
Why?
Chromosomes, Human, Pair 22
1
2006
46
0.010
Why?
Class I Phosphatidylinositol 3-Kinases
1
2006
111
0.010
Why?
Combined Modality Therapy
1
2009
1271
0.010
Why?
Osteosarcoma
1
2006
100
0.010
Why?
CCAAT-Enhancer-Binding Protein-alpha
1
2005
17
0.010
Why?
Lymphoma, Non-Hodgkin
1
2006
124
0.010
Why?
Exons
1
2006
361
0.010
Why?
CpG Islands
1
2005
175
0.010
Why?
Reference Values
1
2006
796
0.010
Why?
Methylation
1
2005
241
0.010
Why?
Mediator Complex
1
2005
61
0.010
Why?
Reoperation
1
2007
645
0.010
Why?
Pregnancy Outcome
1
2007
503
0.010
Why?
Bone Neoplasms
1
2006
272
0.010
Why?
Proportional Hazards Models
1
2006
1331
0.010
Why?
Emergency Service, Hospital
1
2015
2363
0.010
Why?
Animals
2
2016
38107
0.010
Why?
Histones
1
2005
670
0.010
Why?
Leukemia, Myeloid, Acute
1
2006
702
0.010
Why?
Pregnancy
1
2007
7230
0.010
Why?
Walsh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)